Jaeggi E, Fouron J C, Fournier A, van Doesburg N, Drblik S P, Proulx F
Department of Paediatrics, Sainte-Justine Hospital, University of Montreal, Côte Ste Catherine, Quebec, Canada.
Heart. 1998 Jun;79(6):582-7. doi: 10.1136/hrt.79.6.582.
To determine whether M mode echocardiography can differentiate fetal supraventricular tachycardia according to the ventriculo-atrial (VA) time interval, and if the resulting division into short and long VA intervals holds any relation with clinical presentation, management, and fetal outcome.
Retrospective case series.
23 fetuses with supraventricular tachycardia.
A systematic review of the M mode echocardiograms (for VA and atrioventricular (AV) interval measurements), clinical profile, and final outcome.
19 fetuses (82.6%) had supraventricular tachycardia of the short VA type (mean (SD) VA/AV ratio 0.34 (0.16); heart rate 231 (29) beats/min). Tachycardia was sustained in six and intermittent in 13. Hydrops was present in three (15.7%). Digoxin, the first drug given in 14, failed to control tachycardia in five. Three of these then received sotalol and converted to sinus rhythm. All fetuses of this group survived. Postnatally, supraventricular tachycardia recurred in three, two having Wolff-Parkinson-White syndrome. Four fetuses (17.4%) had long VA tachycardia (VA/AV ratio 3.89 (0.82); heart rate 226 (10) beats/min). Initial treatment with digoxin was ineffective in all, but sotalol was effective in two. Heart failure caused fetal death in one and premature delivery in one. All three surviving fetuses had recurrences of supraventricular tachycardia after birth: two had the permanent form of junctional reciprocating tachycardia and one had atrial ectopic tachycardia.
Careful measurement of ventriculo-atrial intervals on fetal M mode echocardiography can be used to distinguish short from long VA supraventricular tachycardia and may be helpful in optimising management. Digoxin, when indicated, may remain the drug of choice in the short VA type but appears ineffective in the long VA type.
确定M型超声心动图能否根据心室-心房(VA)时间间期鉴别胎儿室上性心动过速,以及由此将VA间期分为短和长两种类型是否与临床表现、治疗及胎儿结局有关。
回顾性病例系列研究。
23例患有室上性心动过速的胎儿。
对M型超声心动图(用于测量VA和房室(AV)间期)、临床特征及最终结局进行系统回顾。
19例胎儿(82.6%)为短VA型室上性心动过速(平均(标准差)VA/AV比值0.34(0.16);心率231(29)次/分钟)。心动过速持续存在6例,间歇性发作13例。3例(15.7%)出现水肿。14例首先给予地高辛治疗,其中5例未能控制心动过速。这5例中的3例随后接受索他洛尔治疗并转为窦性心律。该组所有胎儿均存活。出生后,3例室上性心动过速复发,其中2例患有预激综合征。4例胎儿(17.4%)为长VA心动过速(VA/AV比值3.89(0.82);心率226(10)次/分钟)。所有胎儿最初用地高辛治疗均无效,但索他洛尔对2例有效。1例因心力衰竭导致胎儿死亡,1例早产。3例存活胎儿出生后室上性心动过速均复发:2例为永久性交界性折返性心动过速,1例为房性异位性心动过速。
仔细测量胎儿M型超声心动图上的心室-心房间期可用于区分短VA和长VA室上性心动过速,可能有助于优化治疗。地高辛在有指征时可能仍是短VA型的首选药物,但对长VA型似乎无效。